SHANGHAI HENLIUS BIOTECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.7 HKD | +2.33% |
|
+9.44% | +20.14% |
| 01/05 | Henlius Biotech Logs 1.35 Billion Yuan Revenue in Q1 | MT |
| 26/04 | Shanghai Henlius Biotech's Cancer Drug Gets the Nod from US FDA | MT |
Chart calendar Shanghai Henlius Biotech, Inc.
a2269c2b4e143d4486b.cpgzxbSfaeRGyRZZ8CgliBrCI7l2wuaQwa5ySKAwOgU.CsBJsPvGAJAOpHMKpRF_51agcfQCht_0iOA_MMQHU3If7naywNA9rzOcdQ~adf02ca8839249cfd404954f2351a4f1
Upcoming events on Shanghai Henlius Biotech, Inc.
Past events on Shanghai Henlius Biotech, Inc.
| 21/03/2024 05:17 pm | Q4 2023 Earnings Release |
| 15/11/2023 05:40 pm | Q3 2023 Earnings Release |
| 28/08/2023 01:00 pm | Extraordinary Shareholders Meeting |
| 25/08/2023 04:56 pm | Q2 2023 Earnings Release |
| 25/05/2023 11:30 am | Annual General Meeting |
| 31/03/2023 | Q4 2022 Earnings Release |
| 18/08/2022 | Interim 2022 Earnings Release |
| 16/03/2022 | FY 2021 Earnings Release |
| 28/09/2021 12:30 pm | Chinese Society of Clinical Oncology Meeting - Zhenggang Ren, Zhongshan Hospital |
| 26/09/2021 02:45 pm | Chinese Society of Clinical Oncology Meeting - Ye Guo, Shanghai East Hospital |
| 26/09/2021 12:54 pm | Chinese Society of Clinical Oncology Meeting - Jusheng An Cancer Hospital Chinese Academy of Medical |
| 26/09/2021 07:57 am | Chinese Society of Clinical Oncology Meeting - Ye Guo Shanghai East Hospital |
| 18/08/2021 | Interim 2021 Earnings Release |
| 20/01/2021 | UBS Greater China Conference |
| 14/01/2021 | Citigroup Greater China Healthcare Corporate Day |
| 13/01/2021 | JP Morgan Healthcare Conference |
| 24/08/2020 | Interim 2020 Earnings Release |
| 12/06/2020 01:00 pm | Extraordinary Shareholders Meeting |
| 23/03/2020 | FY 2019 Earnings Release |
| 19/02/2020 06:30 am | Extraordinary Shareholders Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 90,9 107 -15.35% | 588 584 0.67% | 1 682 1 530 9.98% | 3 215 3 039 5.8% | 5 395 5 075 6.29% | 5 875 |
|
EBITDA Million CNY | Released Forecast Spread | -769 -619 -24.21% | -858 -695 -23.4% | -420 -438 4.21% | -311 165 -288.25% | 1 021 873 17% | 1 083 |
|
EBIT Million CNY | Released Forecast Spread | -851 -651 -30.74% | -994 -792 -25.51% | -620 -606 -2.37% | -324 -640 49.41% | 662 594 11.37% | 751 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -875 -536 -63.21% | -994 -792 -25.41% | -957 -678 -41.2% | -694 -365 -90.13% | 570 479 18.88% | 663 |
|
Net income Million CNY | Released Forecast Spread | -875 -607 -44.22% | -994 -765 -29.82% | -984 -678 -45.23% | -695 -366 -89.99% | 546 466 17.26% | 594 |
|
EPS CNY | Released Forecast Spread | -1,76 -1,30 -34.95% | -1,88 -1,50 -25.48% | -1,83 -1,19 -53.98% | -1,28 -0,74 -72.97% | 1,00 0,86 16.06% | 1,10 |
| Announcement Date | 23/03/20 | 26/03/21 | 16/03/22 | 31/03/23 | 21/03/24 | - |
| 06/05/2024 04:30 pm | AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | BIOTEST AG: Q1 2024 Earnings Release |
| 07/05/2024 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | REVANCE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | APELLIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 07/05/2024 11:30 am | BIOGAIA AB: Q1 2024 Earnings Release |
| 08/05/2024 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release (Projected) |
| 08/05/2024 | INTRA-CELLULAR THERAPIES, INC.: Q1 2024 Earnings Release (Projected) |
| 08/05/2024 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | ZAI LAB LIMITED: Q1 2024 Earnings Release |
Past sector events for Shanghai Henlius Biotech, Inc.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 2696 Stock
- Calendar Shanghai Henlius Biotech, Inc.
